Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients

NCT04389645 is registered in ClinicalTrials.gov with MeMed Diagnostics Ltd. as lead sponsor.

NCT NCT04389645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04389645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients
Lead sponsor
MeMed Diagnostics Ltd.
Phase
Observational
Overall status
Completed
Start date
April 7, 2020
Completion date
May 12, 2020
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19